Product › Details
|Next higher product group||interleukin 2 inhibitor|
|Status||1993-01-01 sales existent|
|Today||Novartis AG (NYSE: NVS)|
Record changed: 2016-02-13
More documents for cyclosporine (INN)
-  Sigmoid Pharma Ltd.. (9/29/14). "Press Release: Sigmoid Enters into a License Agreement with Pendopharm for Commercialisation Rights to CyCol in Canada". Dublin....
-  Novaliq GmbH. (4/11/13). "Press Release: Novaliq GmbH Raises €13.9 Million ($18.1 Million) in 5th Round of Financing". Heidelberg....
-  Novaliq GmbH. (5/2/12). "Press Release: Novaliq Receives €3.9 Million in further Round of Financing Talks". Heidelberg....
-  to-BBB Technologies B.V.. (9/29/11). "Press Release: NeuroVive and to-BBB Awarded Eurostars Grant for Development of Stroke Therapy". Lund & Leiden....
-  Merck KGaA. (2/19/09). "Press Release: European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva". Darmstadt....
-  Johnson & Johnson. (1/22/09). "Press Release: New Biologic Stelara Receives Approval in Europe for Treatment of Moderate to Severe Plaque Psoriasis. First and Only Biologic Approved with Infrequent, every Twelve-week Maintenance Dosing". Beerse....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to email@example.com and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]